Your browser doesn't support javascript.
loading
How Digital Solutions Might Provide a World of New Opportunities for Holistic and Empathic Support of Patients with Hidradenitis Suppurativa.
Boucher, Annie; Peters, Martin; Jones, Graham B.
Affiliation
  • Boucher A; Novartis Pharma AG, Lichtstrasse 35, 4056, Basel, Switzerland.
  • Peters M; Novartis Pharma AG, Lichtstrasse 35, 4056, Basel, Switzerland.
  • Jones GB; Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA. graham.jones@tufts.edu.
Article in En | MEDLINE | ID: mdl-39042318
ABSTRACT
Hidradenitis suppurativa (HS) is a complex chronic relapsing inflammatory condition anchored in the hair follicle wherein painful abscesses, nodules, and tunnels form under the skin with the potential for intermittent pus drainage and tissue scarring. Current estimates of incidence are 1-4% globally with the disease three times more prevalent in women and higher rates among Black populations. Patients with HS are also more likely to suffer from depression, anxiety, and loneliness underscoring the need for carefully approached strategies on disease awareness and interventions. Delays in formal diagnosis, which have been estimated at 7-10 years on average, impede timely provision of optimal care. Despite best intent, when patients present at a physician's office, stigmas relating to physical appearance can be exacerbated by negative interactions experienced by patients. In addition to long wait times and the dearth of available HS expert dermatology professionals, patients perceive heightened physician focus on two of the HS flare risk factors (smoking and body mass index [BMI]) as negatively impacting their care. Given the need for continual, personal, and sensitive patient support, herein we advocate for re-examination of approach to care and the leveraging of highly personalized digital support solutions. New medications which can directly or indirectly control elements of the disease and its comorbidities are also entering the marketplace. Collectively, we posit that these new developments provide opportunity for a holistic approach for patients with HS, leading to long-term engagement and improved outcomes.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Dermatol Ther (Heidelb) Year: 2024 Document type: Article Affiliation country: Suiza

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Dermatol Ther (Heidelb) Year: 2024 Document type: Article Affiliation country: Suiza